Marco Bongiovanni

1.5k total citations
54 papers, 696 citations indexed

About

Marco Bongiovanni is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marco Bongiovanni has authored 54 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 22 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Marco Bongiovanni's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV-related health complications and treatments (13 papers). Marco Bongiovanni is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV-related health complications and treatments (13 papers). Marco Bongiovanni collaborates with scholars based in Italy, Switzerland and United Kingdom. Marco Bongiovanni's co-authors include Antonella d’Arminio Monforte, Teresa Bini, Paola Cicconi, Federica Tordato, Elisabetta Chiesa, Fulvio Adorni, Camilla Tincati, Sara Melzi, Andrea Antinori and Andrea De Luca and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Marco Bongiovanni

49 papers receiving 670 citations

Peers

Marco Bongiovanni

VIROL

EPIDE

ONCOL

Eric Billaud France

Gerald Pierone United States

Pierre de Truchis France

Evelyn Hogg United States

J Falloon United States

Tomoko Uehira Japan

Juan Carlos López Spain

Joop E. Arends Netherlands

Michael Stek United States

Suzaan Marais South Africa

Eric Billaud France

Marco Bongiovanni

185 ×0.5

115 ×0.5

VIROL

152 ×0.7

182 ×1.2

EPIDE

69 ×0.5

ONCOL

Citations per year, relative to Marco Bongiovanni Marco Bongiovanni (= 1×) peers Eric Billaud

Countries citing papers authored by Marco Bongiovanni

Since Specialization

Citations

This map shows the geographic impact of Marco Bongiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bongiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bongiovanni more than expected).

Fields of papers citing papers by Marco Bongiovanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Bongiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bongiovanni. The network helps show where Marco Bongiovanni may publish in the future.

Co-authorship network of co-authors of Marco Bongiovanni

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Bongiovanni. A scholar is included among the top collaborators of Marco Bongiovanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Bongiovanni. Marco Bongiovanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bongiovanni, Marco, et al.. (2025). Oritavancin in a patient with recurrent endocarditis by Enterococcus faecalis: a new therapeutic option?. Journal of Antimicrobial Chemotherapy. 80(10). 2873–2874.

Schindler, Christian, et al.. (2024). Breaking the Dogma of Intravenous Treatment for Infective Endocarditis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(24). 7518–7518. 2 indexed citations

Bongiovanni, Marco, et al.. (2024). Clinical Findings of Listeria monocytogenes Infections with a Special Focus on Bone Localizations. Microorganisms. 12(1). 178–178. 1 indexed citations

Bernasconi, Enos, et al.. (2023). A case of spondylodiscitis by Ureaplasma urealyticum in an immunocompetent adult with spine stabilization. International Journal of Infectious Diseases. 131. 127–129. 1 indexed citations

Bongiovanni, Marco, et al.. (2023). Pseudomonas aeruginosa Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review. Journal of Clinical Medicine. 12(6). 2252–2252. 10 indexed citations

Bongiovanni, Marco, et al.. (2021). Pantoea Agglomerans Bacteremia: A Real Pathogen? A Case Report and Review of the Literature. 2(2).

Bongiovanni, Marco, et al.. (2021). Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection. Journal of Infection. 82(4). e13–e14. 5 indexed citations

Bongiovanni, Marco & Alessandro Maria Marra. (2020). COVID-19 infection as a systemic disease. 7(1). 2 indexed citations

Bongiovanni, Marco, et al.. (2008). Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects. Medicinal Chemistry. 4(6). 513–519. 5 indexed citations

10.

Bongiovanni, Marco, Andrea Gori, Alessandro Cozzi Lepri, et al.. (2007). Is the CD4 Cell Percentage a Better Marker of Immunosuppression than the Absolute CD4 Cell Count in HIV-Infected Patients with Cirrhosis?. Clinical Infectious Diseases. 45(5). 650–653. 7 indexed citations

11.

Bongiovanni, Marco, et al.. (2006). Long-Term Immunologic Outcome in HAART-Experienced Subjects Receiving Lopinavir/Ritonavir. AIDS Research and Human Retroviruses. 22(11). 1096–1105. 1 indexed citations

12.

Larussa, Dora, P Lorenzini, Antonella Cingolani, et al.. (2006). Highly Active Antiretroviral Therapy Reduces the Age-Associated Risk of Dementia in a Cohort of Older HIV-1-Infected Patients. AIDS Research and Human Retroviruses. 22(5). 386–392. 32 indexed citations

13.

Bongiovanni, Marco. (2006). Treatment interruptions in HIV-infected subjects. Journal of Antimicrobial Chemotherapy. 58(3). 502–505. 16 indexed citations

14.

Bongiovanni, Marco & Federica Tordato. (2006). Tenofovir Plus Didanosine as Nrti Backbone in HIV-Infected Subjects. Current Medicinal Chemistry. 13(23). 2789–2793. 7 indexed citations

15.

Fausto, Alfonso, Marco Bongiovanni, Paola Cicconi, et al.. (2005). Potential predictive factors of osteoporosis in HIV-positive subjects. Bone. 38(6). 893–897. 74 indexed citations

16.

Monforte, Antonella d’Arminio & Marco Bongiovanni. (2005). Cerebrovascular disease in highly active antiretroviral therapy–treated individuals: Incidence and risk factors. Journal of NeuroVirology. 11(0). 34–37. 3 indexed citations

17.

Bongiovanni, Marco, Paola Cicconi, Simona Landonio, et al.. (2005). Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals. International Journal of Antimicrobial Agents. 26(1). 88–91. 29 indexed citations

18.

Bongiovanni, Marco, Elisabetta Chiesa, Antonio Di Biagio, et al.. (2005). Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART. Journal of Antimicrobial Chemotherapy. 55(6). 1003–1007. 4 indexed citations

19.

Bongiovanni, Marco, Elisabetta Chiesa, Agostino Riva, Antonella d’Arminio Monforte, & Teresa Bini. (2003). Avascular necrosis of the femoral head in a HIV-1 infected patient receiving lopinavir/ritonavir. International Journal of Antimicrobial Agents. 22(6). 630–631. 7 indexed citations

20.

Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact